Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,735 public trials 964 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

NCT00255606

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Helsinki University Central Hospital Helsinki, Finland
  • Kainuu Central Hospital Kajaani, Finland
  • Keski-Pohjanmaa Central Hospital Kokkola, Finland
  • Kymenlaakso Central Hospital Kotka, Finland
View all 19 locations
View Trial Details
Completed

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

NCT00316927

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, England, United Kingdom
  • Burnley General Hospital Burnley, England, United Kingdom
  • Kent and Canterbury Hospital Canterbury, England, United Kingdom
  • Eastbourne District General Hospital Eastbourne, England, United Kingdom
View all 15 locations
View Trial Details
Completed

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00016393

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • CCOP - Atlanta Regional Atlanta, Georgia, United States
  • Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines, Illinois, United States
View all 28 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer

NCT00992186

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Orange City, Florida, United States
  • Ann Arbor, Michigan, United States
  • Charleston, South Carolina, United States
  • Antwerp, Belgium
View all 13 locations
View Trial Details

Related conditions